Your browser doesn't support javascript.
loading
Design, synthesis, and structure-activity relationships of tetrahydroquinoline-based farnesyltransferase inhibitors.
Lombardo, Louis J; Camuso, Amy; Clark, John; Fager, Krista; Gullo-Brown, Johnni; Hunt, John T; Inigo, Ivan; Kan, David; Koplowitz, Barry; Lee, Francis; McGlinchey, Kelly; Qian, Ligang; Ricca, Carolyn; Rovnyak, George; Traeger, Sarah; Tokarski, John; Williams, David K; Wu, Laurence I; Zhao, Yufen; Manne, Veeraswamy; Bhide, Rajeev S.
Afiliação
  • Lombardo LJ; Bristol-Myers Squibb Pharmaceutical Research Institute, PO Box 4000, Princeton, NJ 08543-4000, United States. louis.lombardo@bms.com
Bioorg Med Chem Lett ; 15(7): 1895-9, 2005 Apr 01.
Article em En | MEDLINE | ID: mdl-15780629
ABSTRACT
Tetrahydroquinoline-based small molecule inhibitors of farnesyltransferase (FT) have been identified. Lead compounds were shown to have nanomolar to sub-nanomolar activity in biochemical assays with excellent potency in a Ras-mutated cellular reversion assay. BMS-316810 (9e), a 0.7 nM FT inhibitor, was orally-active in a nude mouse tumor allograft efficacy study.
Assuntos
Buscar no Google
Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Quinolinas / Alquil e Aril Transferases / Inibidores Enzimáticos / Antineoplásicos Limite: Animals Idioma: En Ano de publicação: 2005 Tipo de documento: Article
Buscar no Google
Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Quinolinas / Alquil e Aril Transferases / Inibidores Enzimáticos / Antineoplásicos Limite: Animals Idioma: En Ano de publicação: 2005 Tipo de documento: Article